Figure 3.

Healthcare costs per-patient-per-year (USD 2019) per indicator of suboptimal treatment subgroup during the 12 months following the landmark period for patients with CD using conventional agents during the landmark period (N = 6072) (biologic costs included the injection costs from the medical claims and the medication costs from the pharmacy claims; pharmacy costs excluded biologic costs; medical costs excluded biologic costs; only suboptimal treatment subgroup representing more than >5% of patients are shown, see Supplementary Table S3 for details). Abbreviations: CD, Crohn’s disease; ED, emergency department; IP, inpatient; USD, United States dollars.